Arcus Biosciences (RCUS) Prepaid Assets (2017 - 2026)
Arcus Biosciences (RCUS) recorded quarterly Prepaid Assets of $19.0 million in Q1 2026, up 26.67% quarter-over-quarter from $15.0 million in Q4 2025, and little changed on a YoY basis from $19.0 million in Q1 2025.
Arcus Biosciences (RCUS) Prepaid Assets (2017 - 2026) Analysis & Trends
Arcus Biosciences' Prepaid Assets history runs 10 years deep, the most recent figure standing at $19.0 million for Q1 2026.
- In Q1 2026, Prepaid Assets changed 0.0% year-over-year to $19.0 million; the TTM figure through Mar 2026 stood at $19.0 million (changed 0.0% YoY), while the FY2025 annual figure was $15.0 million, down 16.67% from the prior year.
- Prepaid Assets was $19.0 million for Q1 2026 at Arcus Biosciences, up from $15.0 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $34.0 million in Q4 2023 to a low of $15.0 million in Q3 2025.
- Historically, Prepaid Assets has averaged $22.2 million across 5 years, with a median of $20.0 million in 2025.
- The sharpest annual moves came in 2022 and 2024: Prepaid Assets soared 113.44% in 2022, then slumped 47.06% in 2024.
- A 5-year view of Prepaid Assets shows it stood at $19.0 million in 2022, then soared by 78.95% to $34.0 million in 2023, then plunged by 47.06% to $18.0 million in 2024, then retreated by 16.67% to $15.0 million in 2025, then rose by 26.67% to $19.0 million in 2026.
- The last three Prepaid Assets figures came in at $19.0 million (Q1 2026), $15.0 million (Q4 2025), and $15.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Arcus Biosciences | 3.05 Bn | 2.23 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.00 Mn |
| Dec 31, 2025 | 15.00 Mn |
| Sep 30, 2025 | 15.00 Mn |
| Jun 30, 2025 | 20.00 Mn |
| Mar 31, 2025 | 19.00 Mn |
| Dec 31, 2024 | 18.00 Mn |
| Sep 30, 2024 | 22.00 Mn |
| Jun 30, 2024 | 25.00 Mn |
| Mar 31, 2024 | 34.00 Mn |
| Dec 31, 2023 | 34.00 Mn |
| Sep 30, 2023 | 31.00 Mn |
| Jun 30, 2023 | 22.00 Mn |
| Mar 31, 2023 | 28.00 Mn |
| Dec 31, 2022 | 19.00 Mn |
| Sep 30, 2022 | 21.63 Mn |
| Jun 30, 2022 | 15.67 Mn |
| Mar 31, 2022 | 18.53 Mn |
| Dec 31, 2021 | 18.00 Mn |
| Sep 30, 2021 | 17.57 Mn |
| Jun 30, 2021 | 21.97 Mn |